|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Trading: NO POSITION @ $0.105
Signal Strength: MEDIUM
Indicator can be used in isolation but is strengthened by additional indicator confirmation. Indicator can be applied to the short or medium term timeframe and is able to highlight a potential change in price direction. This bar analysis can provide guidance on the daily battle between sellers and buyers from the companies recent trading.
Impedimed (ASX:IPD)No bar reversal is present for Impedimed. Over the last 12 months there have been 5 occurrences of no bar reversals giving a signal probability of 1.9%.
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
|LNG Liquefied Natural Gas||0.12||9.1||340,710||0||NEUTRAL|
|OSP Osprey Medical||0.02||6.3||143,313||0||NEUTRAL|
|MAQ Macquarie Telecom||28.5||6.1||4,846||0||NEUTRAL|
|JHC Japara Healthcare||0.97||4.9||745,332||0||NEUTRAL|
|SPL Starpharma Holdings||1.2||4.8||106,685||0||NEUTRAL|
|VAH Virgin Australia Holdings||0.13||4||596,964||0||NEUTRAL|
|TBR Tribune Resources||5.3||3.9||38,686||0||NEUTRAL|
|FDV Frontier Digital Ventures||1.14||3.6||44,326||0||NEUTRAL|